260 related articles for article (PubMed ID: 12622426)
41. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer.
Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP
Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962
[TBL] [Abstract][Full Text] [Related]
42. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Wang W; Lönnroth C; Lundholm K
Int J Cancer; 2007 Jul; 121(2):232-40. PubMed ID: 17290397
[TBL] [Abstract][Full Text] [Related]
43. COX-2 is expressed in human pulmonary, colonic, and mammary tumors.
Soslow RA; Dannenberg AJ; Rush D; Woerner BM; Khan KN; Masferrer J; Koki AT
Cancer; 2000 Dec; 89(12):2637-45. PubMed ID: 11135226
[TBL] [Abstract][Full Text] [Related]
44. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
46. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
[TBL] [Abstract][Full Text] [Related]
47. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
48. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
Yu LL; Yu HG; Yu JP; Luo HS
Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
[TBL] [Abstract][Full Text] [Related]
49. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma.
Hashimoto Y; Kondo Y; Kimura G; Matsuzawa I; Sato S; Ishizaki M; Imura N; Akimoto M; Hara S
Histopathology; 2004 Apr; 44(4):353-9. PubMed ID: 15049901
[TBL] [Abstract][Full Text] [Related]
51. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
52. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
[TBL] [Abstract][Full Text] [Related]
53. Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
Kawamoto T; Shoda J; Asano T; Ueda T; Furukawa M; Koike N; Tanaka N; Todoroki T; Miwa M
Int J Cancer; 2002 Mar; 98(3):427-34. PubMed ID: 11920595
[TBL] [Abstract][Full Text] [Related]
54. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
55. Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance.
Xiong B; Sun TJ; Hu WD; Cheng FL; Mao M; Zhou YF
World J Gastroenterol; 2005 Feb; 11(8):1105-8. PubMed ID: 15754389
[TBL] [Abstract][Full Text] [Related]
56. Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer.
Konno H; Baba M; Shoji T; Ohta M; Suzuki S; Nakamura S
Clin Exp Metastasis; 2002; 19(6):527-34. PubMed ID: 12405290
[TBL] [Abstract][Full Text] [Related]
57. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.
Kim MH; Seo SS; Song YS; Kang DH; Park IA; Kang SB; Lee HP
Gynecol Oncol; 2003 Jul; 90(1):83-90. PubMed ID: 12821346
[TBL] [Abstract][Full Text] [Related]
58. Association between cyclooxygenase-2-expressing macrophages, ulceration and microvessel density in colorectal cancer.
Sheehan KM; Steele C; Sheahan K; O'Grady A; Leader MB; Murray FE; Kay EW
Histopathology; 2005 Mar; 46(3):287-95. PubMed ID: 15720414
[TBL] [Abstract][Full Text] [Related]
59. [Expression of cyclooxygenase-2 in esophageal squamous cell carcinogenesis].
Yu HP; Liu L; Shi LY; Lu WH; Xu SQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Jan; 38(1):22-5. PubMed ID: 14989896
[TBL] [Abstract][Full Text] [Related]
60. Localization of cyclo-oxygenase-2 in human recurrent colorectal cancer.
Loukanov Ts; Kirilov M; Fürstenberger G; Müller-Decker K
Clin Invest Med; 2010 Feb; 33(1):E22-9. PubMed ID: 20144265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
